Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 4
2000 2
2001 3
2002 3
2003 7
2004 4
2006 1
2007 2
2010 2
2011 1
2012 3
2013 3
2014 3
2015 3
2016 3
2017 2
2018 2
2019 3
2020 3
2021 7
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
TRAP1 Chaperones the Metabolic Switch in Cancer.
Wengert LA, Backe SJ, Bourboulia D, Mollapour M, Woodford MR. Wengert LA, et al. Biomolecules. 2022 Jun 4;12(6):786. doi: 10.3390/biom12060786. Biomolecules. 2022. PMID: 35740911 Free PMC article. Review.
Decrypting the chaperone code.
Truman AW, Bourboulia D, Mollapour M. Truman AW, et al. J Biol Chem. 2021 Jan-Jun;296:100293. doi: 10.1016/j.jbc.2021.100293. Epub 2021 Feb 16. J Biol Chem. 2021. PMID: 33837727 Free PMC article. No abstract available.
Targeting Hsp90 in urothelial carcinoma.
Chehab M, Caza T, Skotnicki K, Landas S, Bratslavsky G, Mollapour M, Bourboulia D. Chehab M, et al. Oncotarget. 2015 Apr 20;6(11):8454-73. doi: 10.18632/oncotarget.3502. Oncotarget. 2015. PMID: 25909217 Free PMC article. Review.
Targeting extracellular Hsp90: A unique frontier against cancer.
Sager RA, Khan F, Toneatto L, Votra SD, Backe SJ, Woodford MR, Mollapour M, Bourboulia D. Sager RA, et al. Front Mol Biosci. 2022 Aug 17;9:982593. doi: 10.3389/fmolb.2022.982593. eCollection 2022. Front Mol Biosci. 2022. PMID: 36060252 Free PMC article. Review.
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.
Sager RA, Backe SJ, Ahanin E, Smith G, Nsouli I, Woodford MR, Bratslavsky G, Bourboulia D, Mollapour M. Sager RA, et al. Nat Rev Urol. 2022 May;19(5):305-320. doi: 10.1038/s41585-022-00571-8. Epub 2022 Mar 9. Nat Rev Urol. 2022. PMID: 35264774 Free PMC article. Review.
67 results